Neratinib Completed Phase 1 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00864487Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib
NCT00757809Study Evaluating The Tolerability Of Multiple Doses Of HKI-272
NCT00814060Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)
NCT00380328HKI-272 Ketoconazole Drug Interaction Study
NCT00366600Study Evaluating HKI-272 Administered to Healthy Subjects
NCT00860223Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin
NCT00550212Study Evaluating Oral Administrations of HKI-272 in Healthy Male Subjects